Micardis (Telmisartan) - Summary

MICARDIS SUMMARY

Micardis^®
(telmisartan)
Tablets, 20 mg, 40 mg and 80 mg

MICARDIS® (telmisartan) is a nonpeptide angiotensin II receptor (type AT₁) antagonist.

MICARDIS (telmisartan) is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

MICARDIS NEWS HIGHLIGHTS

Media Articles Related to Micardis (Telmisartan)

Trial Shows Micardis(R) (telmisartan) Reduces The Risk Of Cardiovascular Death, Heart Attack And Stroke In ACE-Intolerant High-Risk Patients
Source: Stroke / Neuroprotection News From Medical News Today [2008.09.01]

ESC: Telmisartan Fails as Substitute for ACE Inhibitors
Source: MedPage Today Cardiovascular [2008.09.03]

Telmisartan Shown To Reduce Outcome Of Cardiovascular Death, Heart Attack Or Stroke In Global Study
Source: Hypertension News From Medical News Today [2008.09.01]

Telmisartan Modestly Reduces Major Cardiovascular Events In Patients Unable To Tolerate Ace Inhibitors (Transcend Study)
Source: Diabetes News From Medical News Today [2008.08.31]

Disability Due To Recurrent Stroke No Different When Using Two Different Anticlotting Regimens Or Telmisartan (PRoFESS Study)
Source: Stroke / Neuroprotection News From Medical News Today [2008.08.30]

more>>

Published Studies Related to Micardis (Telmisartan)

Meta-analysis of randomized controlled trials comparing telmisartan with losartan in the treatment of patients with hypertension. [2008.05]

Telmisartan, ramipril, or both in patients at high risk for vascular events. [2008.04.10]

Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial. [2008.02]

Effect of telmisartan on forearm postischemic hyperemia and serum asymmetric dimethylarginine levels. [2007.12]

Both ramipril and telmisartan reverse indices of early diabetic cardiomyopathy: a comparative study. [2007.12]

more>>

Clinical Trials Related to Micardis (Telmisartan)

Telmisartan80mg/hydrochlothiazide12.5mg (Micardis Plus) ABPM Study in China [Completed]

INNOVATION Study - Telmisartan (Micardis?) in Incipient Diabetic Nephropathy [Completed]

Telmisartan80/HCTZ25 Versus telmisartan80/HCTZ12.5 in Hypertension Not Responding to telmisartan80/HCTZ12.5 [Completed]

Trial of Telmisartan 80mg/HCTZ 12.5mg and Telmisartan 40mg/HCTZ 12.5mg in Patients With Hypertension [Completed]

Non-Responder Study to Telmisartan 40mg [Completed]

more>>